Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine by Sinovac Biotech for Seasonal Influenza: Likelihood of Approval
Influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine is under clinical development by Sinovac Biotech...
Data Insights
SA-58 by Sinovac Biotech for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
SA-58 is under clinical development by Sinovac Biotech and currently in Phase III for Coronavirus Disease 2019 (COVID-19). According to...